Veracyte, Inc. (VCYT)
Largest Insider Buys in Sector
VCYT Stock Price History Chart
VCYT Stock Performance
About Veracyte, Inc.
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer diagnosis; Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis; and Immunoscore Colon Cancer test for colon cancer diagnosis. It is also developing Percepta Genomic Atlas to help inform lung cancer treatment decisions; Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. Veracyte, Inc. has technology licensing and collaboration arrangements with Johnson & Johnson; Acerta Pharma; and CareDx. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Activity of Veracyte, Inc.
Over the last 12 months, insiders at Veracyte, Inc. have bought $0 and sold $6M worth of Veracyte, Inc. stock.
On average, over the past 5 years, insiders at Veracyte, Inc. have bought $525,242 and sold $43.59M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 60,000 shares for transaction amount of $980,094 was made by Stapley Marc (Chief Executive Officer) on 2022‑06‑10.
List of Insider Buy and Sell Transactions, Veracyte, Inc.
| 2024-11-27 | Sale | VP, Chief Accounting Officer | 5,032 0.0065% | $42.89 | $215,834 | +0.14% | ||
| 2024-11-19 | Sale | director | 14,731 0.0188% | $38.34 | $564,768 | -0.33% | ||
| 2024-11-12 | Sale | Chief Financial Officer | 15,275 0.0198% | $38.34 | $585,663 | +3.53% | ||
| 2024-11-12 | Sale | director | 15,000 0.0195% | $38.32 | $574,830 | +3.53% | ||
| 2024-09-19 | Sale | director | 5,173 0.0067% | $35.23 | $182,263 | -2.38% | ||
| 2024-09-04 | Sale | Chief Commercial Officer-CLIA | 5,479 0.0072% | $29.78 | $163,159 | +16.02% | ||
| 2024-08-13 | Sale | director | 24,326 0.0341% | $32.04 | $779,456 | +6.20% | ||
| 2024-08-13 | Sale | director | 47,645 0.0671% | $32.20 | $1.53M | 0.00% | ||
| 2024-08-12 | Sale | director | 200 0.0003% | $30.00 | $6,001 | +13.08% | ||
| 2024-08-09 | Sale | director | 1,778 0.0024% | $30.03 | $53,391 | +15.48% | ||
| 2024-08-07 | Sale | director | 5,108 0.0075% | $30.32 | $154,883 | +24.84% | ||
| 2024-08-07 | Sale | director | 5,000 0.007% | $29.00 | $145,000 | +24.84% | ||
| 2024-07-16 | Sale | Chief Commercial Officer-CLIA | 1,277 0.0019% | $25.00 | $31,925 | +29.58% | ||
| 2024-07-16 | Sale | director | 7,500 0.0109% | $25.00 | $187,500 | +29.58% | ||
| 2024-07-16 | Sale | director | 5,000 0.0071% | $24.50 | $122,500 | +29.58% | ||
| 2024-06-11 | Sale | director | 3,870 0.0049% | $20.59 | $79,683 | +51.71% | ||
| 2024-06-10 | Sale | director | 3,870 0.0049% | $20.32 | $78,634 | +54.55% | ||
| 2024-06-07 | Sale | director | 2,500 0.0033% | $20.97 | $52,425 | +55.62% | ||
| 2024-05-28 | Sale | director | 1,539 0.002% | $21.00 | $32,319 | +48.21% | ||
| 2024-04-01 | Sale | director | 10,000 0.0133% | $21.65 | $216,528 | +9.70% |
Insider Historical Profitability
| Chambers Rebecca | Chief Financial Officer | 124501 0.1606% | $42.95 | 0 | 1 | |
| Leite John | Chief Commercial Officer-CLIA | 76174 0.0983% | $42.95 | 0 | 2 | |
| EPSTEIN ROBERT S | director | 44598 0.0575% | $42.95 | 0 | 2 | |
| Wygant Jonathan | VP, Chief Accounting Officer | 42313 0.0546% | $42.95 | 0 | 1 | |
| Holstein Jens | director | 27878 0.036% | $42.95 | 1 | 3 | +12.01% |
| Bhanji Muna | director | 23105 0.0298% | $42.95 | 0 | 4 | |
| EASTHAM KARIN | director | 18497 0.0239% | $42.95 | 0 | 12 | |
| JONES EVAN/ FA | director | 0 0% | $42.95 | 0 | 43 | |
| Stapley Marc | Chief Executive Officer | 159761 0.2061% | $42.95 | 1 | 0 | +45.22% |
| Kennedy Keith | COO / CFO | 119632 0.1544% | $42.95 | 0 | 8 | |
| Hanna John Walter JR | Chief Commercial Officer | 74309 0.0959% | $42.95 | 0 | 14 | |
| Kennedy Giulia C | Chief Scientific & Med Officer | 65970 0.0851% | $42.95 | 0 | 29 | |
| Anderson Bonnie H | director | 42681 0.0551% | $42.95 | 4 | 51 | +38.63% |
| BISHOP JOHN L | director | 33125 0.0427% | $42.95 | 0 | 2 | |
| Hall Christopher M | President and COO | 28714 0.0371% | $42.95 | 0 | 16 | |
| Ho Mark | 19086 0.0246% | $42.95 | 0 | 1 | ||
| GORDON KEVIN K | 8720 0.0113% | $42.95 | 0 | 3 | ||
| Brooks Julie | EVP,General Counsel, Secretary | 3122 0.004% | $42.95 | 4 | 0 | <0.0001% |
| TREU JESSE I | director | 0 0% | $42.95 | 0 | 6 | |
| Cohen Fred E | director | 0 0% | $42.95 | 0 | 1 | |
| Guyer Shelly D | Chief Financial Officer | 0 0% | $42.95 | 0 | 3 |
Institutional Investor Ownership
| The Vanguard Group | $163.65M | 9.66 | 7.38M | +3.75% | +$5.91M | <0.01 | |
| Wellington Management Company | $163.26M | 9.64 | 7.37M | +4.23% | +$6.63M | 0.03 | |
| BlackRock | $159.8M | 9.43 | 7.21M | +0.69% | +$1.1M | <0.01 | |
| ARK Investment Management LLC | $156.07M | 9.21 | 7.04M | -8.01% | -$13.58M | 0.54 | |
| State Street | $95.89M | 5.66 | 4.33M | +39.19% | +$27M | <0.01 | |
| Dimensional Fund Advisors | $76.79M | 4.53 | 3.47M | +2.75% | +$2.05M | 0.02 | |
| Nikko Asset Management Americas Inc | $74.01M | 4.38 | 3.35M | +7.82% | +$5.37M | 0.55 | |
| Sumitomo Mitsui Trust Holdings | $74.18M | 4.38 | 3.35M | +7.82% | +$5.38M | 0.05 | |
| Artisan Partners | $68.25M | 4.03 | 3.08M | -4.29% | -$3.06M | 0.1 | |
| Champlain Investment Partners, LLC | $59.78M | 3.53 | 2.7M | +23.28% | +$11.29M | 0.34 | |
| Arrowmark Colorado Holdings Llc | $58.57M | 3.46 | 2.64M | +5.01% | +$2.79M | 0.15 | |
| Geode Capital Management | $37.68M | 2.22 | 1.7M | +5.17% | +$1.85M | <0.01 | |
| Bank of America | $33.71M | 1.99 | 1.52M | +81.22% | +$15.11M | <0.01 | |
| GW&K Investment Management | $30.93M | 1.83 | 1.4M | -1.39% | -$434,744.46 | 0.27 | |
| Bamco | $24.73M | 1.46 | 1.12M | +46.28% | +$7.82M | 0.07 | |
| Nuveen | $22.77M | 1.34 | 1.03M | +0.5% | +$114,079.68 | 0.01 | |
| Goldman Sachs | $21.65M | 1.28 | 977,089 | -19.64% | -$5.29M | <0.01 | |
| Northern Trust | $21.42M | 1.26 | 966,482 | -1.36% | -$295,060.40 | <0.01 | |
| Granite Investment Partners Llc | $20.29M | 1.2 | 915,750 | +4.87% | +$941,777.84 | 0.77 | |
| Fisher Asset Management Llc | $19.56M | 1.15 | 882,467 | +0.83% | +$161,900.95 | 0.01 | |
| New York State Common Retirement Fund | $19.11M | 1.13 | 862,583 | +3% | +$556,575.24 | 0.03 | |
| Casdin Capital | $19.01M | 1.12 | 857,904 | New | +$19.01M | 0.94 | |
| William Blair Investment Management | $16.43M | 0.97 | 741,651 | +0.89% | +$145,679.84 | 0.04 | |
| Charles Schwab | $16.24M | 0.96 | 732,775 | +4.92% | +$761,351.12 | <0.01 | |
| Oberweis Asset Management Inc | $14.88M | 0.88 | 671,700 | +2.27% | +$329,962.40 | 1.08 | |
| Candriam S C A | $14.87M | 0.88 | 670,937 | +9.82% | +$1.33M | 0.1 | |
| Fiera Capital | $13.7M | 0.81 | 618,317 | -3.13% | -$442,823.26 | 0.04 | |
| Eventide Asset Management | $12.5M | 0.74 | 564,000 | 0% | +$0 | 0.2 | |
| Legal & General | $11.77M | 0.7 | 530,935 | +42.27% | +$3.5M | <0.01 | |
| Morgan Stanley | $11.18M | 0.66 | 504,620 | -14.72% | -$1.93M | <0.01 | |
| Renaissance Technologies | $10.86M | 0.64 | 489,900 | +513.14% | +$9.09M | 0.02 | |
| Man Group Plc | $10.43M | 0.62 | 470,648 | +8.96% | +$857,724.90 | 0.03 | |
| Mirae Asset Global Investments Co Ltd | $9.61M | 0.61 | 465,992 | +66.39% | +$3.83M | 0.01 | |
| JENNISON ASSOCIATES LLC | $9.12M | 0.54 | 411,540 | +4.42% | +$386,160.27 | 0.01 | |
| Invesco | $7.94M | 0.47 | 358,374 | +8.81% | +$643,304.81 | <0.01 | |
| Granahan Investment Management | $7.58M | 0.45 | 342,264 | -32.08% | -$3.58M | 0.27 | |
| Qube Research & Technologies | $7.59M | 0.45 | 342,417 | +158.15% | +$4.65M | 0.01 | |
| Segall Bryant & Hamill | $7.18M | 0.42 | 323,926 | +18.73% | +$1.13M | 0.14 | |
| Rafferty Asset Management Llc | $6.84M | 0.4 | 308,559 | +93.5% | +$3.3M | 0.02 | |
| Silverarc Capital Management Llc | $6.22M | 0.37 | 280,773 | +13.34% | +$732,388.04 | 0.06 | |
| Citigroup | $6.06M | 0.36 | 273,408 | +257.04% | +$4.36M | <0.01 | |
| Nordea Investment Management Ab | $6.05M | 0.36 | 272,176 | +232.27% | +$4.23M | 0.01 | |
| Duquesne Family Office Llc | $5.76M | 0.34 | 259,944 | New | +$5.76M | 0.16 | |
| Efg Asset Management North America Corp | $5.69M | 0.34 | 257,388 | +12.08% | +$613,785.70 | 0.99 | |
| Parkman Healthcare Partners Llc | $5.63M | 0.33 | 254,092 | +7.07% | +$371,756.18 | 0.7 | |
| BNY Mellon | $5.54M | 0.33 | 250,197 | -14.18% | -$916,359.24 | <0.01 | |
| UBS | $5.26M | 0.31 | 237,148 | +39.82% | +$1.5M | <0.01 | |
| Voloridge Investment Management, LLC | $4.77M | 0.28 | 215,215 | New | +$4.77M | 0.02 | |
| AMI Asset Management Corp. | $4.51M | 0.27 | 203,723 | +7.17% | +$301,819.49 | 0.23 | |
| Franklin Templeton Investments | $4.5M | 0.27 | 202,966 | +465.25% | +$3.7M | <0.01 |